| 1 |
Oudijk MA, Ruskamp JM, Ververs FFT, et al. Treatment of fetal tachycardia with sotalol: transplacental pharmacokinetics and pharmacodynamics[J]. J Am Coll Cardiol, 2003, 42(4): 765-770.
|
| 2 |
Gopinathannair R, Merchant FM, Lakkireddy DR, et al. COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies[J]. J Interv Card Electrophysiol, 2020, 59(2): 329-336.
|
| 3 |
Driggin E, Madhavan MV, Bikdeli B, et al. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic[J]. J Am Coll Cardiol, 2020, 75(18): 2352-2371.
|
| 4 |
邓小博, 马欢欢, 俞荣, 等. 新冠病毒感染后细胞免疫研究进展 [J].中华医院感染学杂志, 2022, 32(10): 1590-1595.
|
| 5 |
Coromilas EJ, Kochav S, Goldenthal I, et al. Worldwide survey of COVID-19-associated arrhythmias[J]. Circ Arrhythm Electrophysiol, 2021, 14(3): e009458.
|
| 6 |
Salem D, Katranji F, Bakdash T. COVID-19 infection in pregnant women: Review of maternal and fetal outcomes[J]. Int J Gynaecol Obstet, 2021, 152(3): 291-298.
|
| 7 |
Valdespino-Vázquez MY, Helguera-Repetto CA, León-Juárez M, et al. Fetal and placental infection with SARS-CoV-2 in early pregnancy[J]. J Med Virol, 2021, 93(7): 4480-4487.
|
| 8 |
Patel D, Cuneo B, Viesca R, et al. Digoxin for the treatment of fetal congestive heart failure with sinus rhythm assessed by cardiovascular profile score[J]. J Matern Fetal Neona, 2008, 21(7): 477-482.
|
| 9 |
Warda RM. Pharmacology of the maternal-placental-fetal-unit and fetal therapy[J]. Prog Pediatr Cardiol, 1996, 5(2): 79-89.
|